267 related articles for article (PubMed ID: 33841624)
1. IGFBP-1 in cancer: expression, molecular mechanisms, and potential clinical implications.
Lin YW; Weng XF; Huang BL; Guo HP; Xu YW; Peng YH
Am J Transl Res; 2021; 13(3):813-832. PubMed ID: 33841624
[TBL] [Abstract][Full Text] [Related]
2. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
3. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells.
Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY
Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor binding protein-related protein 1 and cancer.
Zhu S; Xu F; Zhang J; Ruan W; Lai M
Clin Chim Acta; 2014 Apr; 431():23-32. PubMed ID: 24513543
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration.
Fu P; Liang GJ; Khot SS; Phan R; Bach LA
J Cell Physiol; 2010 Sep; 224(3):636-43. PubMed ID: 20432455
[TBL] [Abstract][Full Text] [Related]
6. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5.
Ewton DZ; Coolican SA; Mohan S; Chernausek SD; Florini JR
J Cell Physiol; 1998 Oct; 177(1):47-57. PubMed ID: 9731744
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-binding protein-4 inhibits epithelial growth and proliferation in the rodent intestine.
Austin K; Tsang D; Chalmers JA; Maalouf MF; Brubaker PL
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G206-G219. PubMed ID: 29631376
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition.
Oh SH; Lee OH; Schroeder CP; Oh YW; Ke S; Cha HJ; Park RW; Onn A; Herbst RS; Li C; Lee HY
Mol Cancer Ther; 2006 Nov; 5(11):2685-95. PubMed ID: 17121915
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells.
Mohan S; Nakao Y; Honda Y; Landale E; Leser U; Dony C; Lang K; Baylink DJ
J Biol Chem; 1995 Sep; 270(35):20424-31. PubMed ID: 7544787
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility.
Massoner P; Colleselli D; Matscheski A; Pircher H; Geley S; Jansen Dürr P; Klocker H
Endocr Relat Cancer; 2009 Sep; 16(3):795-808. PubMed ID: 19509068
[TBL] [Abstract][Full Text] [Related]
11. Expression of insulin-like growth factor binding protein 1-6 genes in adrenocortical tumors and pheochromocytomas.
Ilvesmäki V; Liu J; Heikkilä P; Kahri AI; Voutilainen R
Horm Metab Res; 1998 Oct; 30(10):619-23. PubMed ID: 9851669
[TBL] [Abstract][Full Text] [Related]
12. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
[TBL] [Abstract][Full Text] [Related]
13. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH
J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275
[TBL] [Abstract][Full Text] [Related]
14. Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts.
Conover CA; Clarkson JT; Bale LK
Endocrinology; 1995 Apr; 136(4):1403-10. PubMed ID: 7534698
[TBL] [Abstract][Full Text] [Related]
15. The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities.
Oh Y
Kidney Res Clin Pract; 2012 Mar; 31(1):26-37. PubMed ID: 26889406
[TBL] [Abstract][Full Text] [Related]
16. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
Le H; Arnold JT; McFann KK; Blackman MR
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of the concentrations of IGFs and several IGF-binding proteins in a large fibrous abdominal tumor and the circulation of a patient with hypoglycemia.
van Doorn J; van de Hoef W; Dullaart RP
Biofactors; 2015 May; 41(3):183-9. PubMed ID: 26073062
[TBL] [Abstract][Full Text] [Related]
18. IGFBP-4 and PAPP-A in normal physiology and disease.
Hjortebjerg R
Growth Horm IGF Res; 2018 Aug; 41():7-22. PubMed ID: 29864720
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance and impact on outcomes of the gene expression levels of
Yamamoto N; Oshima T; Yoshihara K; Aoyama T; Hayashi T; Yamada T; Sato T; Shiozawa M; Yoshikawa T; Morinaga S; Rino Y; Kunisaki C; Tanaka K; Akaike M; Imada T; Masuda M
Oncol Lett; 2017 May; 13(5):3958-3966. PubMed ID: 28521493
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
Price WA; Moats-Staats BM; Stiles AD
Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
